Industry Report: Virtual Value: A Market Survey on The Shift to Digital Scientific Discourse in Pharma and Biotech
In an August 2022 market research study, more than 600 medical science liaisons (MSLs) weighed in on virtual vs in-person engagements with potential key opinion leaders (KOLs); how it impacted their day-to day work and why even with more digital tools available - the same industry challenge persists - finding diverse and relevant KOLs to support getting critical drugs and therapies to market. Find out how they feel about in-person vs virtual meetings and why finding digital opinion thought leaders continues to be a struggle.